Template:Current week ecosystem agenda: Difference between revisions
From Bioblast
Tindle Lisa (talk | contribs) No edit summary |
Tindle Lisa (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
2023 Week 21 | 2023 Week 21 | ||
*'''May- 22 Mo''' | *'''May- 22 Mo''' - Type 2 Diabetes Prevention Week | ||
---- | ---- | ||
*'''May- 23 Tu''' | *'''May- 23 Tu''' | ||
:::: '''»[[Pint of Science 2023 Innsbruck AT]]«''' | :::: '''»[[Pint of Science 2023 Innsbruck AT]]«''' | ||
:::: '''19:00 [[Gnaiger Erich|Erich Gnaiger]] presenting at [[Pint of Science 2023 Innsbruck AT]]''' - ''Body mass excess and decline of mitochondrial fitness'' | :::: '''19:00 [[Gnaiger Erich|Erich Gnaiger]] presenting at [[Pint of Science 2023 Innsbruck AT]]''' - ''Body mass excess and decline of mitochondrial fitness'' | ||
| Line 14: | Line 14: | ||
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]] | | width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]] | ||
|'''"Such markers [of mitochondrial function] could help to identify metabolic changes before the disease becomes irreversible and at a stage where therapeutic and lifestyle intervention could be more effective, thus reducing the burden of the health and economic costs of this epidemic."'''<br> | |'''"Such markers [of mitochondrial function] could help to identify metabolic changes before the disease becomes irreversible and at a stage where therapeutic and lifestyle intervention could be more effective, thus reducing the burden of the health and economic costs of this epidemic."'''<br> | ||
* Calabria E, Muollo V, Cavedon V, Capovin T, Saccenti L, Passarotti F, Ghiotto L, Milanese C, Gelati M, Rudi D, Salvagno GL, Lippi G, Tam E, Schena F, Pogliaghi S (2023) Type 2 | * Calabria E, Muollo V, Cavedon V, Capovin T, Saccenti L, Passarotti F, Ghiotto L, Milanese C, Gelati M, Rudi D, Salvagno GL, Lippi G, Tam E, Schena F, Pogliaghi S (2023) Type 2 diabetes related mitochondrial defects in peripheral mononucleated blood cells from overweight postmenopausal women. [[Calabria 2023 Biomedicines|»Bioblast link«]] | ||
:from the O2k-Network »[[IT Verona Venturelli M]]« | :from the O2k-Network »[[IT Verona Venturelli M]]« | ||
|} | |} | ||
Revision as of 08:16, 22 May 2023
- Oroboros declares solidarity against the Russian aggression-war in Ukraine and against all aggression-wars worldwide. - »More details
- -» A future for Ukraine is the future of its science
2023 Week 21
- May- 22 Mo - Type 2 Diabetes Prevention Week
- May- 23 Tu
- »Pint of Science 2023 Innsbruck AT«
- 19:00 Erich Gnaiger presenting at Pint of Science 2023 Innsbruck AT - Body mass excess and decline of mitochondrial fitness
- May- 24 We
- May- 25 Th
"Such markers [of mitochondrial function] could help to identify metabolic changes before the disease becomes irreversible and at a stage where therapeutic and lifestyle intervention could be more effective, thus reducing the burden of the health and economic costs of this epidemic."
- Calabria E, Muollo V, Cavedon V, Capovin T, Saccenti L, Passarotti F, Ghiotto L, Milanese C, Gelati M, Rudi D, Salvagno GL, Lippi G, Tam E, Schena F, Pogliaghi S (2023) Type 2 diabetes related mitochondrial defects in peripheral mononucleated blood cells from overweight postmenopausal women. »Bioblast link«
- from the O2k-Network »IT Verona Venturelli M«
- May- 26 Fr
